Home / Inspections / 1115488

FDA Inspection 1115488 — Acella Pharmaceuticals, LLC

Acella Pharmaceuticals, LLC — FEI 3006691461

The FDA completed an inspection of Acella Pharmaceuticals, LLC on January 7, 2020 in Alpharetta, GA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 7, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Alpharetta, GA (United States)

Facility

Other inspections at this facility

  • 1322218 (NAI Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1232099 (VAI Wed Dec 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1197977 (VAI Fri Feb 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1152922 (OAI Fri Sep 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1085822 (VAI Fri Mar 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources